Liver Carboxylesterase 1 (CES1) Human shRNA Lentiviral Particle (Locus ID 1066)
CAT#: TL313972V
CES1 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.
Need custom lentivirus service?
Get a free quote
CNY 11,400.00
货期*
详询
规格
Cited in 1 publication. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | Liver Carboxylesterase 1 (CES1) Human shRNA Lentiviral Particle (Locus ID 1066) |
Locus ID | 1066 |
Synonyms | ACAT; CE-1; CEH; CES2; hCE-1; HMSE; HMSE1; PCE-1; REH; SES1; TGH |
Vector | pGFP-C-shLenti |
Format | Lentiviral particles |
RefSeq | NM_001025194, NM_001025195, NM_001266, NM_001025194.1, NM_001266.1, NM_001266.2, NM_001266.3, NM_001266.4, NM_001025195.1, BC012418, BC012418.1, BC009706, BC110338, NM_001266.5, NM_001025195.2 |
Summary | This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This enzyme is the major liver enzyme and functions in liver drug clearance. Mutations of this gene cause carboxylesterase 1 deficiency. Three transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Jun 2010] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Impaired cholesterol efflux in retinal pigment epithelium of individuals with juvenile macular degeneration
,Tsai, YT;Li, Y;Ryu, J;Su, PY;Cheng, CH;Wu, WH;Li, YS;Quinn, PMJ;Leong, KW;Tsang, SH;,
American journal of human genetics
,PubMed ID 33909993
[CES1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...